Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 6/20 | 0.44 |
| ▸ | LIPG | Q9Y5X9 | 6/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL119235 | 0.82 | LPL (0.50) | LPLLIPG | |
| SCHEMBL2768124 | 0.81 | LPL (0.49) | LPLLIPG | |
| SCHEMBL2768064 | 0.81 | LPL (0.49) | LPLLIPG | |
| SCHEMBL13410397 | 0.79 | LPL (0.55) | LPLLIPG | |
| SCHEMBL13410351 | 0.79 | LPL (0.55) | LPLLIPG | |
| SCHEMBL12276242 | 0.79 | LPL (0.55) | LPLLIPG | |
| SCHEMBL12122383 | 0.79 | LPL (0.55) | LPLLIPG | |
| SCHEMBL1568941 | 0.78 | LPL (0.54) | LPLLIPG | |
| SCHEMBL16806600 | 0.77 | LPL (0.41) | LPLLIPG | |
| SCHEMBL10019510 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2669916-A1 | Ruthenium complex and dye-sensitized fuel cell using the same | Samsung SDI Co., Ltd. (KR) | 2013-12-04 | — | — | EP | disclosed |
| US-20110240110-A1 | RUTHENIUM COMPLEX AND DYE-SENSITIZED FUEL CELL USING THE SAME | c/o Samsung SDI Co., Ltd. (KR) | 2011-10-06 | — | — | US | disclosed |
| EP-2372734-A2 | Ruthenium complex and dye-sensitized fuel cell using the same | Samsung SDI Co., Ltd. (KR) | 2011-10-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110240110-A1 | RUTHENIUM COMPLEX AND DYE-SENSITIZED FUEL CELL USING THE SAME | LAGE3, TST, MDH2 | LPL 4705/4885LIPG 3462/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.